REGENERON PHARMACEUTICALS (REGN)       741.48  +5.25 (+0.71%)

741.48  +5.25 (+0.71%)

US75886F1075 - Common Stock - After market: 741.48 0 (0%)

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
13.71B16.07B8.50B7.86B6.71B
Non Recurring Items
N/AN/AN/AN/AN/A
Cost Of Goods
2.00B2.44B1.12B782.20M434.10M
Gross Profit
11.71B13.63B7.38B7.08B6.28B
Operating Expenses
5.25B4.69B3.80B4.87B3.74B
Operating Income
6.46B8.95B3.58B2.21B2.53B
Interest Expense
-314.40M328.80M139.10M88.10M13.70M
Income Before Taxes
6.04B9.33B3.81B2.43B2.55B
Income Tax
667.20M1.25B297.20M313.30M177.10M
Net Income
5.37B8.08B3.51B2.12B2.44B
EBITDA
6.77B9.23B3.81B2.42B2.68B
 
Per Share Data
EPS Diluted Total Ops
47.4071.9730.5218.4621.29
Non GAAP EPS
51.1671.3831.6524.6422.83
 
Statistics
Gross Profit Margin
85.39%84.83%86.82%90.05%93.53%
Profit Margin
39.17%50.25%41.35%26.91%36.42%
Operating Profit Margin
47.10%55.67%42.09%28.10%37.77%

All data in USD

Charts